Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

A woman is excited as she reads the latest rumour on her phone.

Image source: Getty Images

AGL Energy Limited (ASX: AGL)

According to a note out of UBS, its analysts have retained their buy rating on this energy giant's shares with a trimmed price target of $11.25. This follows the release of a first half result that was well ahead of the broker's expectations. UBS sees scope for further earnings outperformance in the coming years if its generation availability can be maintained. The AGL share price is trading at $8.72 on Monday.

News Corp (ASX: NWS)

Another note out of UBS reveals that its analysts have retained their buy rating on this media company's shares with an improved price target of $50.40. The broker was pleased with the company's performance during the December quarter and expects more of the same in the future thanks to its digital business. So, with its shares trading on lower than average multiples, it feels that now is a good time to invest. The News Corp share price is fetching $41.81 this afternoon.

Pro Medicus Limited (ASX: PME)

Analysts at Macquarie have initiated coverage on this health imaging technology company's shares with an outperform rating and $120.00 price target. The broker has been looking at the company's prospects in the US market. It believes Pro Medicus could grow its market share from 7% today to 15% in 2030 and 25% in FY 2035. This follows customer feedback that highlights that its Visage 7 software is faster and more efficient than the competition, The Pro Medicus share price is trading at $108.89 on Monday.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Macquarie says this Gina Rinehart-backed miner could pile on more than 150% in value

A big jump in rare earths resources has the analysts interested.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Broker Notes

Data centre work could help drive this ASX industrial stock to a record high

This company has a track record of strong growth.

Read more »

A view of competitors in a running event, some wearing number bibs, line up together on a starting line looking ahead as if to start a race.
Broker Notes

Buy, hold, sell: Sonic Healthcare, AMP, CBA shares

Let's start the week with some fresh ratings from the experts. 

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Group of people toasting with wine
Broker Notes

Buy, hold, sell: Transurban, Orora, Treasury Wine Estates shares

Here's what top broker Morgans thinks of these 3 ASX 200 shares following their FY26 reports.

Read more »

Businessman studying a high technology holographic stock market chart.
Broker Notes

8 ASX 200 shares with fresh buy ratings this week

Brokers retained a positive view on Westpac, Sonic Healthcare, Minerals 260, and other shares.

Read more »

Woman working on her laptop at a café.
Broker Notes

7 ASX 200 shares downgraded by the experts this week

Brokers reduced their ratings on IAG, Seek, Woolworths, and other ASX 200 stocks.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans names 3 ASX shares to buy

The broker has good things to say about these shares. Here's what you need to know.

Read more »